Current Opinion (Current Drugs)
(Redirected from Curr. Opin. Mol. Ther.)
Current Opinion is a series of medical journals published by Current Drugs from 1998 to 2010. Current Drugs was acquired by Thomson Corporation in 2004.[1]
Journals in the series included:
- Current Opinion in Drug Discovery & Development (ISSN 1367-6733)
- Current Opinion in Investigational Drugs (ISSN 0967-8298), established in 1992 continued as Expert Opinion on Investigational Drugs in 1994
- Current Opinion in Investigational Drugs (ISSN 1472-4472), established in 2000, formed by the merger of
- Current Opinion in Anti-infective Investigational Drugs (ISSN 1464-8458)
- Current Opinion in Anti-inflammatory & Immunomodulatry Investigation Drugs (ISSN 1464-8474)
- Current Opinion in Cardiovascular, Pulmonary and Renal Investigational Drugs (ISSN 1464-8482)
- Current Opinion in Central & Peripheral Nervous System Investigational Drugs (ISSN 1464-844X)
- Current Opinion in Oncologic, Endocrine & Metabolic Investigational Drugs (ISSN 1464-8466)
- Current Opinion in Molecular Therapeutics (ISSN 1464-8431)
References
[edit]- ^ "Current Drugs Ltd. sold to Thomson Corp. - Free Online Library". Retrieved 2019-10-21.
This set index article includes a list of related items that share the same name (or similar names).
If an internal link incorrectly led you here, you may wish to change the link to point directly to the intended article.
If an internal link incorrectly led you here, you may wish to change the link to point directly to the intended article.
  | This article about a medical journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |